Table 1.
Authors | Year | Ethnicity | Study design | Type of control group | Variant | Case/control | HWE p value | Ref. |
---|---|---|---|---|---|---|---|---|
Medeiros et al. | 2002 | Caucasians | Case‐control | Healthy controls | rs1799983 | 125/153 | 0.63 | 17 |
4a/b | 0.42 | |||||||
Medeiros et al. | 2002 | Caucasians | Case‐only | – | rs1799983 | 161/‐ | – | 18 |
Medeiros et al. | 2003 | Caucasians | Case‐only | – | 4a/b | 61/‐ | – | 25 |
Marangoni et al. | 2006 | Caucasians | Case‐control | BPH patients | rs1799983 | 84/65 | 0.79 | 19 |
Jacobs et al. | 2008 | Approximately 97% Caucasians | Case‐control | Noncancer | rs1799983 | 1,425/1,453 | 0.07 | 13 |
Marangoni et al. | 2008 | Caucasians | Case‐control | BPH patients | rs2070744 | 83/94 | 0.71 | 20 |
Lee et al. | 2009 | Non‐Hispanic Caucasians | Case‐control | Non‐PCa | rs1799983 | 1,213/1,433 | 0.94 | 21 |
African Americans | Case‐control | Non‐PCa | rs1799983 | 107/409 | 0.51 | |||
Sanli et al. | 2011 | Caucasians | Case‐control | Healthy controls | 4a/b | 132/158 | 0.88 | 26 |
Ziaei et al. | 2013 | Caucasians | Case‐control | BPH patients | rs1799983 | 95/111 | 0.92 | 22 |
Safarinejad et al. | 2013 | Caucasians | Case‐control | Healthy controls | rs1799983 | 170/340 | 0.10 | 23 |
rs2070744 | 0.22 | |||||||
4a/b | 0.11 | |||||||
Branković et al. | 2013 | Caucasians | Case‐control | Healthy controls | rs1799983 | 150/100 | 0.69 | 24 |
rs2070744 | 0.56 | |||||||
BPH patients | rs1799983 | 150/150 | 0.70 | |||||
rs2070744 | 0.66 |